Young Investigator Grants attract and train early career scientists for lymphoma research through three distinct programs:
Disease-Specific Focus Areas grants are given to senior researchers studying specific subtypes and/or patient populations, including but not limited to:
New focus area-specific grants are developed as financial resources become available. Requests for further information should be directed to email@example.com.
NOTE: Lymphoma Research Foundation reserves the right to change deadlines, forms, and guidelines, plus any and all details pertaining to grant availability, rules, eligibility criteria, selection process, etc. All LRF Research Grants are dependent on funding availability.
If you would like to learn more about how you can invest in LRF's Research Program, please click here.
A cornerstone of LRF's grants portfolio, the Young Investigator Grants have consisted of the Clinical Research Career Development Award and Postdoctoral Fellowship grants since 2002. Beginning with the 2014 cycle, the Foundation added the LRF Clinical Research Mentoring Program (LCRMP), which provides hands on career development and networking opportunities to early career scientists.
A part of LRF's grant portfolio since 1992, Fellowships support investigators who have completed two years of their institutional fellowship and no more than two years of their first faculty position. Grantees must spend at least 80 percent of their time in research; their two year award provides salary support, professional development, and research expenses. Past awardees have completed research projects in both the clinic and laboratory in a variety of lymphoma subtypes, including investigations into the biology of lymphoma, pathways for possible novel targeted agents, and patient quality of life.
Clinical Investigator Career Development Awards
Established in 2002, the CDA supports clinical researchers within five years of the completion of their postdoctoral training. Supported by an institutional mentor, grantees must spend at least 35 percent of their time in independent clinical research; their three-year grant provides salary support, professional development, and research expenses. Past awardees have completed clinical research projects in a variety of lymphoma subtypes.
The LCRMP offers mentoring and education to hematology/oncology fellows and junior faculty dedicated to clinical research in the field of non-Hodgkin and Hodgkin lymphoma. Program participants, called LRF Scholars, attend and participate in a week long intensive introductory workshop and follow-up programming intended to enhance the ability of the LRF Scholars to successfully design and administer clinical research studies and successfully apply for future grant funding.
LRF's Disease Focus Area Grants seek to support research in specific subtypes and/or patient populations. Grants have taken a variety of forms including "R01" type grants for senior researchers, collaborative grants across medical disciplines, correlative awards which enhance existing clinical studies, planning grants to develop a plan and supportive data designed to raise funds from government/other major funding sources, and exploratory/developmental grants to help develop a proof of concept, leading to another project and/or funding.
Disease Focus Area Requests for Proposals (RFPs) vary from year to year, as funding is made available. Not every program will be offered each year.
A sampling of Disease Focus Area programs is listed below. For further details, please visit the Request for Proposals archive.
Adolescent/Young Adult (AYA) Lymphoma Cooperative Groups Correlative Studies Grant
Adolescent/young adult patients with lymphoma are an understudied population that would particularly benefit from adjunct studies. This program funds adjunct studies of up to two years to complement and synergize with ongoing lymphoma clinical trials within the National Cancer Institute Cancer Cooperative Groups.
Chronic Lymphocytic Leukemia (CLL) Collaborative Grant
This two-year CLL Collaborative Grant funds high quality research studies in CLL including the study of primary CLL patient samples to assure relevance to the human disease. Proposed research projects are required to incorporate collaborative interactions between/among investigators in different disciplines (e.g. pathology and medical oncology, basic science research and clinical investigators) and/or different institutions.
Diffuse Large B-Cell Lymphoma (DLBCL) Explorations Grant
This two-year DLBCL Explorations Grant funds applications clinically relevant to the improvement of outcomes for patients with DLBCL. Research projects must include the study of primary DLBCL patient samples and involve collaborative interactions between/among investigators in different disciplines (e.g., pathology and hematology/oncology, basic science research and clinical investigators) and/or different institutions.
Follicular Lymphoma Research
This three-year grant funds follicular lymphoma research that includes the study of primary FL patient samples and incorporates collaborative interactions between/among investigators in different disciplines (e.g. pathology and medical oncology, basic science research and clinical investigators) and/or different institutions.
The goal of LRF's Follicular Lymphoma (FL) Research Initiative is to develop novel therapeutic strategies for the treatment of FL. LRF sought proposals that advance the understanding of the human biology of FL or that verify molecular targets for FL therapeutics.
Mantle Cell Lymphoma (MCL) Research
In 2003, LRF started the Mantle Cell Lymphoma Initiative to accelerate the pace of research in mantle cell lymphoma (MCL). LRF-funded MCL research projects have ranged from laboratory studies to the identification of new therapeutic approaches, including clinical trials of novel agents, chemo immunotherapy, radiation therapy and stem cell transplantation. The grant types described above for CLL, DLBCL and FL have also been offered for MCL. Future MCL grant opportunities are dependent on the availability of funds.
For more information on active grants and the application process, please see the following: